Time
Days to earnings13
Next print2026-10-29
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
BMY
Bristol-Myers Squibb Company primary
57.58
Full stocks workspace →-1.53-2.6%
Street
Consensus EPS1.612
Consensus revenue12.7B
EPS high / low1.87 / 1.03 · 52.1% · n=21
Rev / avg0 / — · 1.73 / 1.733
Options
IV front34.7%
Implied move7.5%
Put/call full1.02
Put/call front0.78
Short interest
Short shares45.8M / 42.0M · +9.24%
Days to cover3.01
Avg vol · float15.2M · 2.0B
Short % float2.25%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 13 | 2026-10-29 | 57.58 | 1.612 | 34.7% | 7.5% | -2.1% | -9.9% | -10.2% | -13.5% | 1.87 / 1.03 | 52.1% | 21 | 1.02 | 0 | |
| 2026-10-09 | 14 | 2026-10-29 | 59.11 | 1.73 | 29.8% | 7.0% | -3.3% | -6.0% | -7.1% | -11.7% | 1.92 / 1.59 | 19.1% | 21 | 1.04 | 0 | |
| 2026-10-08 | 15 | 2026-10-29 | 59.56 | 1.73 | 29.8% | 7.1% | -3.1% | -3.2% | -6.6% | -11.9% | 1.92 / 1.59 | 19.1% | 21 | 1.04 | 0 | |
| 2026-10-07 | 16 | 2026-10-29 | 59.68 | 1.73 | 31.2% | 7.7% | -4.4% | -2.4% | -7.3% | -12.1% | 1.92 / 1.59 | 19.1% | 21 | 1.04 | 0 | |
| 2026-10-06 | 17 | 2026-10-29 | 59.59 | 1.73 | 30.8% | 7.7% | -5.2% | -4.3% | -7.9% | -11.4% | 1.92 / 1.59 | 19.1% | 21 | 1.08 | 0 | |
| 2026-10-05 | 18 | 2026-10-29 | 58.80 | 1.73 | 33.7% | 8.6% | -8.0% | -6.1% | -12.0% | -12.3% | 1.92 / 1.59 | 19.1% | 21 | 1.10 | 0 | |
| 2026-10-02 | 19 | 2026-10-29 | 61.16 | 1.73 | 27.3% | 7.4% | -2.7% | -3.0% | -10.2% | -6.6% | 1.92 / 1.59 | 19.1% | 21 | 1.07 | 0 | |
| 2026-10-01 | 20 | 2026-10-29 | 61.46 | 1.73 | 27.8% | 7.7% | -0.1% | -2.2% | -9.2% | -9.1% | 1.92 / 1.59 | 19.1% | 21 | 1.08 | 0 | |
| 2026-09-30 | 21 | 2026-10-29 | 62.45 | 1.73 | 27.8% | 7.8% | +2.1% | -1.8% | -6.7% | -5.5% | 1.92 / 1.59 | 19.1% | 21 | 1.06 | 0 | |
| 2026-09-29 | 22 | 2026-10-29 | 62.88 | 1.73 | 25.9% | 7.4% | +1.0% | -1.3% | -5.9% | -2.7% | 1.92 / 1.59 | 19.1% | 21 | 1.06 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| PFE primary | Pfizer Inc | 0.59 | 2026Q2 · 2026-08-04 | +13.2% | +0.0% | 25.41 | 16 · 2026-10-12 |
| ABBV primary | AbbVie Inc | 0.51 | 2026Q2 · 2026-07-31 | +0.3% | -1.9% | 250.94 | 14 · 2026-10-12 |
| MRK primary | Merck & Company Inc | 0.49 | 2026Q2 · 2026-08-04 | +50.0% | +0.5% | 128.00 | 13 · 2026-10-12 |
| JNJ primary | Johnson & Johnson | 0.41 | 2026Q2 · 2026-07-15 | +2.1% | -1.5% | 247.02 | 1 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-07-30 | BMO | 2.04 | +28.3% | Beat | -0.6% | +3.5% | 1.75× | -0.3% | Review |
| 2026Q1 | 2026-04-30 | BMO | 1.58 | +11.3% | Beat | +0.2% | +5.0% | 2.97× | -6.3% | Review |
| 2025Q4 | 2026-02-05 | BMO | 1.26 | +5.0% | Beat | +2.2% | +1.0% | 1.92× | +1.9% | Review |
| 2025Q3 | 2025-10-30 | BMO | 1.63 | +7.2% | Beat | +1.6% | +5.4% | 2.79× | +6.6% | Review |
| 2025Q2 | 2025-07-31 | BMO | 1.46 | +32.7% | Beat | -3.9% | -1.9% | 4.07× | +10.4% | Review |
| 2025Q1 | 2025-04-24 | BMO | 1.80 | +20.0% | Beat | -1.2% | +1.6% | 1.22× | -3.7% | Review |
| 2024Q4 | 2025-02-06 | BMO | 1.67 | +13.6% | Beat | -3.9% | +0.1% | 2.24× | -2.8% | Review |
| 2024Q3 | 2024-10-31 | BMO | 1.80 | +20.0% | Beat | +2.2% | +3.7% | 2.53× | +4.9% | Review |
| 2024Q2 | 2024-07-26 | BMO | 2.07 | +27.0% | Beat | +6.6% | +4.5% | 2.16× | -7.4% | Review |
| 2024Q1 | 2024-04-25 | BMO | -4.40 | -6.3% | Miss | -3.0% | -5.7% | 3.95× | +0.1% | Review |